Dongwha Pharm.Co.Ltd (000020) — Capital Reinvestment Ratio
Latest as of March 2026:
5.32x
Dongwha Pharm.Co.Ltd (000020) has a Capital Reinvestment Ratio of 5.32x as of March 2026, meaning it reinvests 5% of its operating cash flow (₩697.02 Million) in capital expenditures (₩3.71 Billion). See 000020 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
5.32x
Capex / Operating Cash Flow
Operating Cash Flow
₩697.02 Million
KRW
Capital Expenditures
₩3.71 Billion
KRW
Data as of
Mar 2026
Most recent filing
Dongwha Pharm.Co.Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Dongwha Pharm.Co.Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Dongwha Pharm.Co.Ltd from 2011 to 2025. For live market cap and broader valuation context, see market value of Dongwha Pharm.Co.Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.52x | ₩15.70 Billion | ₩55.30 Billion | ▲ +290.0% |
| 2023 | 0.90x | ₩29.17 Billion | ₩26.35 Billion | ▲ +43.2% |
| 2022 | 0.63x | ₩29.22 Billion | ₩18.43 Billion | ▲ +3.6% |
| 2021 | 0.61x | ₩36.03 Billion | ₩21.94 Billion | ▼ -7.1% |
| 2020 | 0.66x | ₩52.23 Billion | ₩34.25 Billion | ▲ +81.6% |
| 2019 | 0.36x | ₩13.28 Billion | ₩4.80 Billion | ▲ +267.6% |
| 2016 | 0.10x | ₩25.48 Billion | ₩2.50 Billion | ▲ +120.0% |
| 2015 | 0.04x | ₩19.83 Billion | ₩885.50 Million | ▼ -52.7% |
| 2014 | 0.09x | ₩13.51 Billion | ₩1.28 Billion | ▼ -76.1% |
| 2013 | 0.40x | ₩8.21 Billion | ₩3.24 Billion | ▲ +53.9% |
| 2012 | 0.26x | ₩25.23 Billion | ₩6.48 Billion | ▲ +29.9% |
| 2011 | 0.20x | ₩46.24 Billion | ₩9.15 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow